#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis II Glioblastoma multiforme Dent's disease Chronic myeloid leukaemia (in remission) Cryoglobulinaemia Lupus nephritis Small cell lung cancer recurrent Extranodal marginal zone B-cell lymphoma (MALT type) Pituitary-dependent Cushing's syndrome Non-Hodgkin's lymphoma unspecified histology indolent Carcinoid syndrome Multiple system atrophy Niemann-Pick disease Malignant neoplasm of choroid Dermatitis More trials…

    Learn about Rare Diseases

    Medulloblastoma – Trials in Disease Primary immunodeficiency syndrome – Trials in Disease Mucopolysaccharidosis – Basic Information Antithrombin III deficiency – Life with Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Pleural mesothelioma malignant – Trials in Disease Myxofibrosarcoma – Life with Disease Adrenogenital syndrome – Diagnostics Cerebral arteriovenous malformation haemorrhagic Rhabdoid tumour – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enomimeran Cyclophosphamide Pimecrolimus Rusfertide Calcium Chloride Hexahydrate Mps-216 Timrepigene Emparvovec Dexamethasone Base ZIGAKIBART Timbetasin Acetate LUNRESERTIB Citicoline Sodium Clenbuterol Hydrochloride Ly3437943 Sodium Nimodipine Avb-101 VISUGROMAB Acetylcysteine Amide Gallium (68Ga) Chloride Magnesium Sulfate More therapies…

    Learn about Your Condition

    Ewing's sarcoma metastatic Peritoneal abscess Myocardial infarction Influenza Vascular dementia Diabetic nephropathy Gingival bleeding Schizophreniform disorder Endocarditis bacterial Postpartum haemorrhage Lysosomal storage disorder Mantle cell lymphoma Endocrine ophthalmopathy Intracranial aneurysm Lymphoedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mfoszz Zqadqwbp Kfudm 2kq Duqjimnur 4gvxz Hteziyl

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisone Acetate
    • Fludrocortisone
    • Fludrocortisone Acetate
    Czechia Estonia France Germany Greece Hungary +9

  • Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

    Recruiting

    3 1 1
    Investigated Diseases:
    • Proteinuria
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Vindesine Sulfate
    • Mercaptopurine
    • Daunorubicin
    Austria Belgium Czechia Denmark Finland Germany +8

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Study Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia France Germany Hungary +3

  • Long-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Angiotensin Ii Receptor Blockers (Arbs), Combinations
    • Ace Inhibitors, Plain
    • Angiotensin Ii Receptor Blockers (Arbs), Plain
    Belgium Czechia Denmark France Germany Hungary +7

  • Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Patritumab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Capecitabine
    • Codeine Phosphate
    Belgium Czechia Denmark France Germany Greece +10

  • Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Lisaftoclax
    • Zanubrutinib
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

    Recruiting

    3 1
    Investigated Drugs:
    • Alprazolam
    Bulgaria Czechia Germany Hungary Italy Poland +1
Previous Page
1 … 13 14 15 16 17 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!